journal article·2025-11

Synthesis of CdSe/ZnS quantum dot-aptamer conjugates for epidermal growth factor receptor identification

Oleg N. Karpov, Maria V. Grigoreva, Olga A. Otmakhova, Raisa V. Talroze

Journal of Nanoparticle Research· Volume 27· Issue 11
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Advanced Biosensing Techniques and Applications · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Pandya P, Webster TJ, Ghosh S (2024) Nanobioprospecting of photoautotrophs for the fabrication of quantum dots: mechanism and applications. Front Chem. https://doi.org/10.3389/fchem.2024.145880410.3389/fchem.2024.1458804 ↗
2. Smith AM, Wen MM, Nie S (2010) Imaging dynamic cellular events with quantum dots The bright future. Biochem (Lond) 32(3):1210.1042/BIO03203012 ↗
3. Kairdolf BA, Smith AM, Stokes TH, Wang MD, Young AN, Nie S (2013) Semiconductor quantum dots for bioimaging and biodiagnostic applications. Annu Rev Anal Chem 6(1):143–162. https://doi.org/10.1146/annurev-anchem-060908-15513610.1146/annurev-anchem-060908-155136 ↗
4. Yukawa H, Sato K, Baba Y (2023) Theranostics applications of quantum dots in regenerative medicine, cancer medicine, and infectious diseases. Adv Drug Deliv Rev 200:114863. https://doi.org/10.1016/j.addr.2023.11486310.1016/j.addr.2023.114863 ↗
5. Martins CSM, LaGrow AP, Prior JAV (2022) Quantum dots for cancer-related miRNA monitoring. ACS Sens 7(5):1269–1299. https://doi.org/10.1021/acssensors.2c0014910.1021/acssensors.2c00149 ↗
6. Latronico T, Depalo N, Valente G, Fanizza E, Laquintana V, Denora N, Fasano A, Striccoli M, Colella M, Agostiano A, Curri ML, Liuzzi GM (2016) Cytotoxicity study on luminescent nanocrystals containing phospholipid micelles in primary cultures of rat astrocytes. PLoS ONE 11(4):e0153451. https://doi.org/10.1371/journal.pone.015345110.1371/journal.pone.0153451 ↗
7. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S (2005) In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 16(1):63–72. https://doi.org/10.1016/j.copbio.2004.11.00310.1016/j.copbio.2004.11.003 ↗
8. Gao X, Cui Y, Levenson RM, Chung LW, Nie S (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22(8):969–976. https://doi.org/10.1038/nbt99410.1038/nbt994 ↗
9. Wu L, Zhang Y, Wang Z, Zhang Y, Zou J, Qiu L (2022) Aptamer-based cancer cell analysis and treatment. ChemistryOpen 11(10):e202200141. https://doi.org/10.1002/open.20220014110.1002/open.202200141 ↗
10. Wilbanks BA, Doherty CD, Pearson KS, Jain S, Sarkaria JN (2025) Methods for cell- and tissue-specific DNA aptamer selection. Mol Ther Methods Clin Dev 33(2):101482. https://doi.org/10.1016/j.omtm.2025.10148210.1016/j.omtm.2025.101482 ↗
11. Zhu G, Chen X (2018) Aptamer-based targeted therapy. Adv Drug Deliv Rev 134:65–78. https://doi.org/10.1016/j.addr.2018.08.00510.1016/j.addr.2018.08.005 ↗
12. Ni X, Castanares M, Mukherjee A, Lupold SE (2011) Nucleic acid aptamers: clinical applications and promising new horizons. Curr Med Chem 18(27):4206–4214. https://doi.org/10.2174/09298671179718960010.2174/092986711797189600 ↗
13. Sansare Y, Kejamurthy P, Singh S, Ayush A, Khani K, Ramya Devi KT (2025) Aptamers as therapeutic targets: prospects and progress in the treatment of cancers. Nucleosides, Nucleotides Nucleic Acids 1–39:1. https://doi.org/10.1080/15257770.2025.251285310.1080/15257770.2025.2512853 ↗
14. Nimjee SM, White RR, Becker RC, Sullenger BA (2017) Aptamers as therapeutics. Annu Rev Pharmacol Toxicol 57:61–79. https://doi.org/10.1146/annurev-pharmtox-010716-10455810.1146/annurev-pharmtox-010716-104558 ↗
15. Gao S, Zheng X, Jiao B, Wang L (2016) Post-SELEX optimization of aptamers. Anal Bioanal Chem 408(17):4567–4573. https://doi.org/10.1007/s00216-016-9556-210.1007/s00216-016-9556-2 ↗
16. Zhao X, Dai X, Zhao S, Cui X, Gong T, Song Z, Meng H, Zhang X, Yu B (2021) Aptamer-based fluorescent sensors for the detection of cancer biomarkers. Spectrochim Acta A Mol Biomol Spectrosc 247:119038. https://doi.org/10.1016/j.saa.2020.11903810.1016/j.saa.2020.119038 ↗
17. Sun H, Zhu X, Lu PY, Rosato RR, Tan W, Zu Y (2014) Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther 3:e182. https://doi.org/10.1038/mtna.2014.3210.1038/mtna.2014.32 ↗
18. Coppola G, Cennamo F, Ciccone G, Ibba ML, Ruscio AD, Vito AD, Esposito CL, Catuogno S (2025) Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation. Adv Drug Deliv Rev 224:115639. https://doi.org/10.1016/j.addr.2025.11563910.1016/j.addr.2025.115639 ↗
19. Foubert A, Beloglazova NV, Rajkovic A, Sas B, Madder A, Goryacheva IYu, Saeger S (2016) Bioconjugation of quantum dots: review & impact on future application. TrAC Trends Anal Chem 83:31–48. https://doi.org/10.1016/j.trac.2016.07.00810.1016/j.trac.2016.07.008 ↗
20. Davodabadi F, Mirinejad S, Fathi-Karkan S, Majidpour M, Ajalli N, Sheervalilou R, Sargazi S, Rozmus D, Rahdar A, Diez-Pascual AM (2023) Aptamer-functionalized quantum dots as theranostic nanotools against cancer and bacterial infections: a comprehensive overview of recent trends. Biotechnol Prog 39:e3366. https://doi.org/10.1002/btpr.336610.1002/btpr.3366 ↗
21. Jayanthi VSPKSA, Das AB, Saxena U (2017) Recent advances in biosensor development for the detection of cancer biomarkers. Biosens Bioelectron 91:15–23. https://doi.org/10.1016/j.bios.2016.12.01410.1016/j.bios.2016.12.014 ↗
22. Yang G, Xiao Z, Tang C, Deng Y, Huang H, He Z (2019) Recent advances in biosensor for detection of lung cancer biomarkers. Biosens Bioelectron 141:111416. https://doi.org/10.1016/j.bios.2019.11141610.1016/j.bios.2019.111416 ↗
23. Rajaram P, Chandra P, Ticku S, Pallavi BK, Rudresh KB, Mansabdar P (2017) Epidermal growth factor receptor: role in human cancer. Indian J Dent Res 28(6):687–694. https://doi.org/10.4103/ijdr.IJDR_534_1610.4103/ijdr.IJDR_534_16 ↗
24. Golovin A, Dzarieva F, Rubetskaya K, Shamadykova D, Usachev D, Pavlova G, Kopylov A (2025) In silico born designed anti-EGFR aptamer Gol1 has anti-proliferative potential for patient glioblastoma cells. Int J Mol Sci 26(3):1072. https://doi.org/10.3390/ijms2603107210.3390/ijms26031072 ↗
25. Liu X, Wang P, Zhang C, Ma Z (2017) Epidermal growth factor receptor (EGFR): a rising star in the era of precision medicine of lung cancer. Oncotarget 8:50209–50220. https://doi.org/10.18632/oncotarget.1685410.18632/oncotarget.16854 ↗
26. Sigismund S, Avanzato D, Lanzetti L (2018) Emerging functions of the EGFR in cancer. Mol Oncol 12(1):3–20. https://doi.org/10.1002/1878-0261.1215510.1002/1878-0261.12155 ↗
27. Il’in VA, Pyzhik EV, Balakhonov AB, Kiryushin MA, Shcherbatova EV, Kuznetsov AA, Kostin PA, Golovin AV, Korshun VA, Brylev VA, Sapozhnikova KA, Kopylov AM, Pavlova GV, Pronin IN (2023) Radiochemical synthesis of 4-[18F]FluorobenzylAzide and its conjugation with EGFR-specific aptamers. Molecules 28(1):294. https://doi.org/10.3390/molecules2801029410.3390/molecules28010294 ↗
28. Wu X, Liang H, Tan Y, Yuan C, Li S, Li X, Li G, Shi Y, Zhang X (2014) Cell-SELEX aptamer for highly specific radionuclide molecular imaging of glioblastoma in vivo. PLoS ONE 9(3):e90752. https://doi.org/10.1371/journal.pone.009075210.1371/journal.pone.0090752 ↗
29. Suzuki M, Udaka H, Fukuda T (2017) Quantum dot-linked immunosorbent assay (QLISA) using orientation-directed antibodies. J Pharm Biomed Anal 143:110–115. https://doi.org/10.1016/j.jpba.2017.05.01410.1016/j.jpba.2017.05.014 ↗
30. Wu L, Li X, Shao K, Ye S, Liu C, Zhang C, Han H (2015) Enhanced immunoassay for porcine circovirus type 2 antibody using enzyme-loaded and quantum dots-embedded shell-core silica nanospheres based on enzyme-linked immunosorbent assay. Anal Chim Acta 887:192–200. https://doi.org/10.1016/j.aca.2015.06.02410.1016/j.aca.2015.06.024 ↗
31. Xiao TT, Shi XZ, Jiao HF, Sun AL, Ding H, Zhang RR, Pan DD, Li DX, Chen J (2016) Selective and sensitive determination of cypermethrin in fish via enzyme-linked immunosorbent assay-like method based on molecularly imprinted artificial antibody-quantum dot optosensing materials. Biosens Bioelectron 75:34–40. https://doi.org/10.1016/j.bios.2015.08.01410.1016/j.bios.2015.08.014 ↗
32. Taranova NA, Berlina AN, Zherdev AV, Dzantiev BB (2015) Traffic light’ immunochromatographic test based on multicolor quantum dots for the simultaneous detection of several antibiotics in milk. Biosens Bioelectron 63:255–261. https://doi.org/10.1016/j.bios.2014.07.04910.1016/j.bios.2014.07.049 ↗
33. Howard FB, Miles HT (1965) 6–18-O-purine nucleotides. synthesis and infrared band assignment. J Biol Chem 240:801–805. https://doi.org/10.1016/S0021-9258(17)45246-X10.1016/S0021-9258(17)45246-X ↗
34. Taillandier E, Liquer J (2002) Handbook of vibrational spectroscopy, vol 5. Wiley, Chichester
35. Polyanichko A, Wieser H (2005) Fourier transform infrared/vibrational circular dichroism spectroscopy as an informative tool for the investigation of large supramolecular complexes of biological macromolecules. Biopolymers 78(6):329–339. https://doi.org/10.1002/bip.2029910.1002/bip.20299 ↗
36. Sverdlov LM, Kovner MA, Krainov EP (1970) Vibrational spectra of polyatomic molecules. Nauka, Moscow
37. Wilson EB, Decius JC, Cross PC (1955) The theory of infrared and raman vibrational spectra. McGraw-Hill, New York
38. Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS (1997) Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 8(12):1197–1206. https://doi.org/10.1023/a:100820972052610.1023/a:1008209720526 ↗
39. Harrison PT, Vyse S, Huang PH (2020) Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Semin Cancer Biol 61:167–179. https://doi.org/10.1016/j.semcancer.2019.09.01510.1016/j.semcancer.2019.09.015 ↗
40. Seo D, Lim JH (2024) Targeted therapies for EGFR exon 20 insertion mutation in non-small-cell lung cancer. Int J Mol Sci 25(11):5917. https://doi.org/10.3390/ijms2511591710.3390/ijms25115917 ↗